This clinical trial has just been registered Efficacy and Safety of Artacen for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers Quote: This study will compare the proportion of patients who have wound closure within 12 weeks as well as the time to wound closure in patients receiving Artacent versus standard of care for treatment of non-healing lower extremity wounds. The recurrence of healed wounds will be… Artacent for diabetic foot ulcers
Visit link:
Artacent for diabetic foot ulcers
